Thoracic Cancer | 2019
Metabolic gene NR4A1 as a potential therapeutic target for non‐smoking female non‐small cell lung cancer patients
Abstract
Although cigarette smoking is considered one of the key risk factors for lung cancer, 15% of male patients and 53% of female patients with lung cancer are non‐smokers. Metabolic changes are critical features of cancer. Therapeutic target identification from a metabolic perspective in non‐small cell lung cancer (NSCLC) tissue of female non‐smokers has long been ignored.